Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

AstraZeneca Commits USD 405 Million to UK Life Sciences Amid Policy Shift

AstraZeneca Pharma India gets CDSCO approval for Enhertu for new breast cancer indication

Written By Ruchika Sharma9 May 2025 3:31 PM IST

Bangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation (CDSCO), Directorate...

Senores Pharma to acquire two products of USFDA approved ANDAs from Teva Pharma USA

Senores Pharma buys USFDA approved Tramadol Tablets from APDM Pharma

Written By Ruchika Sharma9 May 2025 1:15 PM IST

The acquisition will be funded through the IPO proceeds raised by Senores Pharmaceuticals Limited.

Zydus Lifesciences bags USFDA nod for Glatiramer Acetate Injection for relapsing forms of Multiple Sclerosis

Written By Ruchika Sharma9 May 2025 12:15 PM IST

It is indicated for the treatment of relapsing forms of Multiple Sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and...

Indoco Remedies arm launches heart attack drug Ticagrelor filmcoated in UK

Lupin wins USFDA okay for HIV-1 drug Raltegravir

Written By Ruchika Sharma9 May 2025 10:15 AM IST

Mumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (USFDA) has approved the Company's...

NPPA Fixes Retail Prices of 37 Drug Formulations Including Atorvastatin, Ezetimibe, Telmisartan, Details

NPPA fixes ceiling prices for 84 drug formulations; focus on Empagliflozin-based Diabetes therapies

Written By Ruchika Sharma8 May 2025 2:14 PM IST

New Delhi: In a fresh directive aimed at curbing treatment costs and improving access to essential medicines, the National Pharmaceutical Pricing...

Lupin Gets USFDA Approval for Xigduo XR Generic Dapagliflozin-Metformin Tablets

Lupin unveils partial onset seizures drug Eslicarbazepine Acetate in US

Written By Ruchika Sharma8 May 2025 12:01 PM IST

Mumbai: Global pharma major Lupin Limited has announced that the company has launched Eslicarbazepine Acetate Tablets, 200 mg, 400 mg, 600...

Shilpa Medicare bags initial authorization for Rotigotine Transdermal Patch from Europe

Shilpa Medicare Unit VI gets GMP approval from EMA

Written By Ruchika Sharma7 May 2025 10:30 AM IST

Karnataka: Shilpa Medicare has announced that the company's Unit VI, Dabaspet, Bengaluru, Karnataka, India has received GMP approval from...

Cipla, Hetero win bid to supply widely prescribed diabetes drug in China

Wockhardt sells USFDA-approved migraine tablet to Senores Pharma

Written By Ruchika Sharma6 May 2025 2:25 PM IST

Ahmedabad: Senores Pharmaceuticals Limited, through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA, has signed an agreement to...

Roche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss Entry

Roche launches Elecsys PRO-C3 test for liver fibrosis

Written By Ruchika Sharma6 May 2025 11:30 AM IST

Basel: Roche has announced the launch of its ElecsysPRO-C3 test, a new diagnostic solution designed to assess the severity of liver fibrosis in...

Roche Itovebi recommended by CHMP for EU approval for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer

EMA Committee recommends EU label update for Roche Phesgo to allow administration outside of clinical settings

Written By Ruchika Sharma4 May 2025 1:30 PM IST

Basel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive...

Bayer new drug application for gadoquatrane accepted for review in China

Bayer begins Phase I study targeting GPC3 with alpha radiopharmaceutical in advanced hepatocellular carcinoma patients

Written By Ruchika Sharma4 May 2025 12:30 PM IST

Berlin: Bayer has announced the initiation of a Phase I clinical trial with 225Ac-GPC3 (BAY 3547926), an investigational targeted alpha...

AstraZenecas Imfinzi Combo Shows Strong Survival Benefit in Liver Cancer Trial

AstraZeneca Breztri met primary endpoints in Phase III trials in asthma

Written By Ruchika Sharma4 May 2025 10:30 AM IST

AstraZeneca has announced the Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok